Prognostic Parameters, Complications, and Oncologic and Functional Outcome of Salvage Radical Prostatectomy for Locally Recurrent Prostate Cancer after 21st-Century Radiotherapy

European Urology

Volumn 57, Issue 3, 2010, Pages 437-445

  Heidenreich, Axel ^a,b   Richter, Stephanie ^a,b   Thüer, David ^b   Pfister, David ^a,b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Extended pelvic lymphadenectomy; External beam radiation; High dose brachytherapy; Incontinence; Low dose brachytherapy; Permanent seed implantation; Radiation failure

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RECURRENT CANCER; RISK FACTOR; SALVAGE THERAPY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 74649086167     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.02.041     Document Type: Article

References (40)

1. Heidenreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 53 (2008) 68-80
2. Roach III M., Lu J., Pilepich M.V., et al. Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials. Int J Radiat Oncol Biol Phys 47 (2000) 609-615
3. Bolla M., Collette L., Blank L., et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360 (2002) 103-108
4. Deger S., Boehmer D., Roigas J., et al. High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer. Eur Urol 47 (2005) 441-448
5. Zelefsky M.J., Kuban D.A., Levy L.B., et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 67 (2007) 327-333
6. Zagars G.K., Kavadi V.S., Pollack A., von Eschenbach A.C., and Sands M.E. The source of pretreatment serum specific antigen in clinically localized prostate cancer-T, N, or M?. Int J Radiat Oncol Biol Phys 32 (1995) 21-32
7. Pontes J.E., Montie J., Klein E., and Huben R. Salvage surgery for radiation failure in prostate cancer. Cancer 71 Suppl (1993) 976-980
8. Brenner P.C., Russo P., Wood D.P., Morse M.J., Donat S.M., and Fair W.R. Salvage radical prostatectomy in the management of locally recurrent prostate cancer after 125I implantation. Br J Urol 75 (1995) 44-47
9. Rogers E., Ohori M., Kassabian V.S., Wheeler T.M., and Scardino P.T. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 153 (1995) 104-110
10. Garzotto M., and Wajsman Z. Androgen deprivation with salvage surgery for radiorecurrent prostate cancer: results at 5-year follow-up. J Urol 159 (1998) 950-954
11. Amling C.L., Lerner S.E., Martin S.K., Slezak J.M., Blute M.L., and Zincke H. Deoxyribonucleid acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol 161 (1999) 857-862
12. Lerner S.E., Blute M.L., and Zincke H. Critical reevaluation of salvage surgery for radio-recurrent/resistant prostate cancer. J Urol 154 (1995) 1103-1109
13. Gheiler E.L., Tefilli M.V., Tiguert R., et al. Predictors for maximal outcome in patients undergoing salvage radical prostatectomy for radiorecurrent prostate cancer. Urology 51 (1998) 789-795
14. Link P., and Freiha F.S. Radical prostatectomy after definitive radiation therapy for prostate cancer. Urology 37 (1991) 189-192
15. Ahlering T.E., Lieskovsky G., and Skinner D.G. Salvage surgery plus androgen deprivation for radioresistant prostatic carcinoma. J Urol 147 (1992) 900-902
16. Cheng L., Sebo T.J., Cheville J.C., et al. Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy. Cancer 83 (1998) 2164-2171
17. Vaidya A., and Soloway M.S. Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited. J Urol 164 (2000) 1998-2001
18. Chen B.T., and Wood Jr. D.P. Salvage prostatectomy in patients who have failed radiation therapy or cryotherapy as primary treatment for prostate cancer. Urology 62 Suppl 6B (2003) 69-78
19. Stephenson A.J., Scardino P.T., Bianco F.J., DiBlasio C.J., Fearn P.A., and Eastham J.A. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 172 (2004) 2239-2243
20. Heidenreich A., Ohlmann C., Özgür E., and Engelmann U.H. Salvage radical prostatectomy in locally recurrent prostate cancer following radiation therapy. Urologe A 45 (2006) 474-481
21. Ward J.F., Sebo T.J., Blute M.L., and Zincke H. Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol 173 (2005) 1156-1160
22. Bianco F.J., Scardino P.T., Stephenson A.J., DiBlasio C.J., Fearn P.A., and Eastham J.A. Longterm oncological results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiation Oncol Biol Phys 62 (2005) 448-453
23. Darras J., Joniau S., and Van Poppel H. Salvage radical prostatectomy for radiorecurrent prostate cancer: indications and results. Eur J Surg Oncol 32 (2006) 964-969
24. Grossfeld G.D., Li Y.P., Lubeck D.P., Broering J.M., Mehta S.S., and Carroll P.R. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol 168 (2002) 530-535
25. Heidenreich A., Ohlmann C.H., and Polyakov S. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. Eur Urol 52 (2007) 29-37
26. Heidenreich A., Varga Z., and Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167 (2002) 1681-1686
27. Rosen R.C., Riley A., Wagner G., Osterloh I.H., Kirkpatrick J., and Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49 (1997) 822-830
28. Wille S., Heidenreich A., Hofmann R., and Engelmann U. Preoperative erectile function is one predictor for post prostatectomy incontinence. Neurourol Urodyn 26 (2007) 140-143
29. Walsh P.C., and Marschke P.L. Intussusception of the reconstructed bladder neck leads to earlier continence after radical prostatectomy. Urology 59 (2002) 934-938
30. Srigley J.R., Amin M.B., Epstein J.I., et al., Members of the Cancer Committee. College of American Pathologists. Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland. Arch Pathol Lab Med 130 (2006) 936-946
31. Kuban D.A., Thames H.D., Levy L.B., et al. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 57 (2003) 915-928
32. Fuks Z., Leibel S.A., Wallner K.E., et al. The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. Int J Radiat Oncol Biol Phys 21 (1991) 537-547
33. Coen J.J., Zietman A.L., Thakral H., and Shipley W.U. Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases. J Clin Oncol 20 (2002) 3199-3205
34. Pollack A., Zagars G.K., Antolak J.A., Kuban D.A., and Rosen I.I. Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized dose escalation trial. Int J Radiat Oncol Biol Phys 54 (2002) 677-685
35. Pucar D., Shukla-Dave A., Hricak H., et al. Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology 236 (2005) 545-553
36. Schilling D., Schlemmer H.P., Wagner P.H., et al. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer. BJU Int 102 (2008) 446-451
37. Heidenreich A., Pfister D., Thüer D., Engelmann U., and Ohlmann C. 11C-choline-positron emission tomography/computed tomography for tumor localization of locally recurrent prostate cancer after radiation therapy. J Urol 177 Suppl (2007) 382 abstract 1159
38. Crook J.M., Malone S., Perry G., et al. Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival: results from a Canadian randomized trial. Cancer 115 (2008) 673-679
39. Kaplan D.J., Crispen P.L., Greenberg R.E., et al. Residual prostate cancer after radiotherapy: a study of radical cystoprostatectomy specimens. Urology 72 (2008) 654-658
40. Nguyen P.L., Chen M.H., D'Amico A.V., et al. Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study. Cancer 110 (2007) 1485-1492